Hikma Pharmaceuticals Diversifies Funding with $500 Million Bond
Deal News | Jul 23, 2025 | White & Case LLP
Hikma Pharmaceuticals has successfully issued a $500 million 5.125% bond due in 2030, with the assistance of the global law firm White & Case LLP. The issuance was managed by Citigroup Global Markets Limited, Emirates NBD Bank PJSC, HSBC Bank plc, Mashreqbank psc, and Mizuho International plc, serving as joint lead managers. This strategic move enables Hikma to diversify its funding sources and access the international debt capital markets effectively. White & Case partner Debashis Dey, along with his team, played a significant role in advising the joint lead managers, helping facilitate the issuance's success. The notes are senior unsecured and listed on the International Securities Market of the London Stock Exchange.
Sectors
- Pharmaceuticals
- Corporate Finance
- Legal Services
Geography
- United Arab Emirates – The legal team from White & Case involved in the transaction is partly based in Dubai.
- United Kingdom – Hikma Pharmaceuticals is listed on the London Stock Exchange, which is in the United Kingdom.
- United States – Hikma Finance USA LLC issued the bonds, thus involving the United States.
Industry
- Pharmaceuticals – The article focuses on Hikma Pharmaceuticals PLC, a major player in the global pharmaceuticals sector, highlighting its financial activities.
- Corporate Finance – The bond issuance is a financial transaction, emphasizing the corporate finance aspects involved in the process.
- Legal Services – White & Case LLP, a global law firm, provided legal advisory services for this transaction.
Financials
- $500 million – The principal amount of the bonds issued by Hikma Finance USA LLC.
- 5.125% – The coupon rate of the bonds issued, indicating the interest paid to investors.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Hikma Pharmaceuticals PLC | Target Company | Company | Hikma Pharmaceuticals is a global pharmaceuticals company that issued the bond. |
| Hikma Finance USA LLC | Bond Issuer | Company | A subsidiary of Hikma Pharmaceuticals responsible for issuing the $500 million bond. |
| White & Case LLP | Legal Advisor | Company | A global law firm that advised the joint lead managers on the bond issuance. |
| Citigroup Global Markets Limited | Joint Lead Manager | Company | One of the major financial institutions managing the bond issuance. |
| Emirates NBD Bank PJSC | Joint Lead Manager | Company | A bank involved as a joint lead manager in the issuance. |
| HSBC Bank plc | Joint Lead Manager | Company | One of the joint lead managers in the bond issuance. |
| Mashreqbank psc | Joint Lead Manager | Company | A bank acting as one of the joint lead managers. |
| Mizuho International plc | Joint Lead Manager | Company | A financial institution serving as a joint lead manager. |
| Debashis Dey | Partner | Person | White & Case partner who led the deal team for this transaction. |